Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BELLUS Health Inc BLUSD


Primary Symbol: T.BLU

BELLUS Health Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. The Company's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The Company has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The Company is focused on initiating Phase III program. The Company is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.


TSX:BLU - Post by User

Bullboard Posts
Post by webpiloton Nov 29, 2011 10:01am
400 Views
Post# 19274047

VIVIMIND works.

VIVIMIND works.IF the truth be known, Vivimind is the only product known to man that actually improves cognition and preserves the memory center of the brain, the hippocampus. There is scientific evidence to support this statement.All prescription drugs offered for sale, all 4 of them simply do not work. In some small way they may help the patient, but only for a very short time. If you want proof of that statement simply go to to the National Institutes of Health website for the US. Absolutely nothing works. So, the first question might be, how did these drugs get approved and believe me that is a very good question. Billions and billions have been spent for these drugs with little or no help in stopping Alzheimer's or even arresting it for a short time.The patients on these drugs simply decline. So, how do we prevent the decline? Vivimind stops the atrophy of the hippocampus and in the future the new product NRM8499 may stop the atrophy by 100%. I have read articles where this is very possible.So, why not use Vivimind in conjunction with one of the approved drugs, it may arrest the decline, you never know.In fact even if a new drug comes along that doesn't completely stop Alzheimer's, using Vivimind to protect the hippocampus might make all the difference in the world.No side effects either. Anyway, Vivimind and NRM8499 appear to have a bright future and may be used in conjunction with any and all new products designed to protect people from Alzheimer's.It appears to me that this patented product and potential new product NRM8499 will provide an enormous benefit and value to any entity that is working on a cure for Alzheimer's.
Bullboard Posts